These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5188852)

  • 1. [Drug therapy and drug resistance in the treatment of tuberculosis].
    Douma J
    Tijdschr Ziekenverpl; 1968 Nov; 21(21):846-9. PubMed ID: 5188852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. V. September 1963 to September 1965.
    Hobby GL; Johnson PM; Crawford-Gagliardi L; Boytar V; Johnson GE
    Am Rev Respir Dis; 1966 Nov; 94(5):703-8. PubMed ID: 4958840
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 7. A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases.
    Eidus L; Jessamine AG; Hershfield ES; Helbecque DM
    Can J Public Health; 1978; 69(2):146-53. PubMed ID: 657071
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comments on the current state of experimental chemotherapy of tuberculosis].
    Urbancík R; Markovic J
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):169-73. PubMed ID: 4971152
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of tuberculosis.
    Bates JH
    Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass ambulatory chemotherapy in the treatment of tuberculosis in a predominantly urban community.
    Moodie AS
    Am Rev Respir Dis; 1967 Mar; 95(3):384-97. PubMed ID: 6018699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pluriresistant tuberculous bacilli in developing countries: value of sensitivity tests with antibiotic combinations].
    Chataigneau P; Castets M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):454-6. PubMed ID: 5510438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proceedings: Tuberculosis therapy. Review on today's knowledge, developmental trends and still open problems].
    Eule H; Krebs A; Iwainsky H
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):78-100. PubMed ID: 4131870
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of tuberculosis. I. Typical Mycobacterium tuberculosis--primary drugs.
    J Kans Med Soc; 1968 Sep; 69(9):445-8. PubMed ID: 4971623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.